XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.2
OPERATING SEGMENTS (Tables)
6 Months Ended
Jun. 30, 2022
OPERATING SEGMENTS  
Schedule of financial information for each of the entity's reportable segments, including the impact of the preceding changes on previously reported full year 2021 net sales and operating income

December 31, 2021

  

  

  

  

2021 Reported

Fixed

2021 Reported

Valued at 2021

  

  

Currency

  

Valued at 2022

(millions)

Management Rates

  

Other

  

Rate Change

  

Management Rates

Net Sales

  

  

  

Global Industrial

$6,304.9

$-

($218.1)

$6,086.8

Global Institutional & Specialty

3,978.2

-

(69.4)

3,908.8

Global Healthcare & Life Sciences

1,195.4

-

(45.8)

1,149.6

Other

1,226.9

-

(25.9)

1,201.0

Corporate

139.4

-

(2.0)

137.4

Subtotal at fixed currency rates

12,844.8

-

(361.2)

12,483.6

Effect of foreign currency translation

(111.7)

-

361.2

249.5

Consolidated reported GAAP net sales

$12,733.1

$-

$-

$12,733.1

Operating Income

Global Industrial

$1,031.0

$4.0

($49.3)

$985.7

Global Institutional & Specialty

556.9

(3.8)

(7.4)

545.7

Global Healthcare & Life Sciences

160.9

(0.9)

(7.7)

152.3

Other

187.3

0.7

(4.0)

184.0

Corporate

(318.6)

2.0

(316.6)

Subtotal at fixed currency rates

1,617.5

-

(66.4)

1,551.1

Effect of foreign currency translation

(18.9)

66.4

47.5

Consolidated reported GAAP operating income

$1,598.6

$-

$-

$1,598.6

Schedule of financial information for each of the entity's reportable segments

Second Quarter Ended

Six Months Ended 

June 30

June 30

(millions)

    

2022

2021

2022

2021

Net Sales

Global Industrial

 

$1,704.1

$1,502.3

$3,261.1

$2,887.2

Global Institutional & Specialty

1,135.1

963.5

2,140.2

1,807.6

Global Healthcare & Life Sciences

400.8

292.0

763.4

573.1

Other

342.3

300.3

638.3

565.7

Corporate

33.9

34.5

68.6

67.3

Subtotal at fixed currency rates

3,616.2

3,092.6

6,871.6

5,900.9

Effect of foreign currency translation

(35.6)

70.1

(24.3)

146.8

Consolidated reported GAAP net sales

 

$3,580.6

 

$3,162.7

$6,847.3

$6,047.7

Operating Income

Global Industrial

 

$227.0

$251.3

$416.2

$461.1

Global Institutional & Specialty

152.6

137.7

263.4

199.6

Global Healthcare & Life Sciences

58.5

46.1

102.6

88.7

Other

52.0

50.8

89.2

83.1

Corporate

(57.9)

(50.9)

(187.5)

(113.4)

Subtotal at fixed currency rates

432.2

435.0

683.9

719.1

Effect of foreign currency translation

(6.4)

12.8

(3.6)

26.0

Consolidated reported GAAP operating income

 

$425.8

 

$447.8

$680.3

$745.1